Clinical Trials
Leukemia, Lymphoma, and Myeloma
- Myeloid and Monocytic LeukemiaA Randomized, Parallel-arm, Phase 2 Clinical Trial of the Combination of Glasdegib (PF-04449913) with Two Standard Decitabine Regimens for Older Patients with Poor-Risk Acute Myeloid Leukemia who are Unfit for or Refuse Intensive ChemotherapyPrincipal Investigator: Amer Zeidan
- Other Hematopoietic, PediatricsAntiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) PBMTC SUP1701Principal Investigator: Niketa Shah
- Leukemia, not otherwise specified, Leukemia, otherA Phase II Pilot Trial to Estimate Survival After a Non-total Body Irradiation (TBI) Based Conditioning Regimen in Patients Diagnosed With B-acute Lymphoblastic Leukemia (ALL) Who Are Pre-allogeneic Hematopoietic Cell Transplantation (HCT) Next-generation-sequence (NGS) Minimal Residual Disease (MRD) NegativePrincipal Investigator: Niketa Shah
- Non-Hodgkin's LymphomaProspective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell LymphomasPrincipal Investigator: Iris Isufi
- Leukemia, other, PediatricsA Phase 3 Trial Investigating Blinatumomab ( NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)Principal Investigator: Nina Kadan-Lottick